Risk factor
Good trading liquidity
Profitability factor
Greatly overvalued vs peers
About
Shanghai Haoyuan Chemexpress Co., Ltd. is dedicated to the innovation and advancement of key compounds for the pharmaceutical industry, focusing on small molecule drugs and their essential intermediates. The company's production capabilities encompass active pharmaceutical ingredients (APIs) and their precursors, various vitamin D series substances, as well as specialized chemical building blocks and life science compounds tailored for contract research organizations (CROs). Established in 2006, its primary operational base is located in Shanghai, China.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EBITDA
Target Price
The average target price of 688131.SS is 107 and suggests 27.8% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to